Status:
COMPLETED
The Role Of Fructose and Uric Acid In the Development of Obesity and Metabolic Syndrome
Lead Sponsor:
Instituto Nacional de Cardiologia Ignacio Chavez
Conditions:
Overweight and Obesity
Metabolic Syndrome
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if a low fructose intake could have an impact on weight loss, uric acid levels and the components of the metabolic syndrome (glucose, cholesterol, triglycerid...
Detailed Description
Overweight and obesity are now considered a growing public health problem in Mexico and worldwide. This epidemic has been attributed to dietary fructose consumption. Although experimental models have ...
Eligibility Criteria
Inclusion
- Individuals with a Body Mass Index (BMI) \> 25. BMI defined as: Weight in kilograms divided by Height (squared) in meters.
- Residents of Mexico city
- Healthy individuals (no comorbidities or drug prescription for associated chronic diseases)
Exclusion
- Diabetes Mellitus Type 1 or 2
- Severe Hypertension (defined as systolic blood pressure \> 160 mmHg and /or diastolic blood pressure \> 100 mmHg) and/or Hypertension on pharmacological treatment.
- Chronic Kidney Disease (Glomerular Filtration Rate (GFR) \< 60 ml/min)
- Hepatic Damage or Advanced Disease (clinical, biochemical or histological)
- Patient receiving any pharmacological treatments for hypercholesterolemia and/or elevated triglycerides.
- Anemia (any etiology)
- Malignancy
- Pregnancy
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2010
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00868673
Start Date
March 1 2009
End Date
February 1 2010
Last Update
July 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Nacional de Cardiología Igancio Chávez
Mexico City, Mexico City, Mexico, 14080